North America Bioresorbable Stent (BRS) Device Market was valued at USD 0.15 Billion in 2022 and is projected to reach USD 0.48 Billion by 2030, growing at a CAGR of 15.50% from 2024 to 2030.
The North American bioresorbable stent (BRS) device market is poised for significant growth due to increasing adoption of innovative medical devices and the rising prevalence of cardiovascular diseases. Bioresorbable stents are designed to offer temporary support to blood vessels during the healing process, and then gradually dissolve over time. This innovative technology has attracted attention in the medical industry, as it reduces the long-term risk of complications compared to traditional metallic stents. As such, the BRS market is heavily influenced by advancements in the healthcare industry, including cutting-edge materials, improved bioengineering processes, and evolving patient requirements.
The primary applications of bioresorbable stents are in coronary artery disease treatment, where they serve as a solution for patients who need a stent but are also concerned about the long-term presence of a foreign object in their bodies. The primary requirement from industries is ensuring that these stents provide the necessary mechanical strength during the critical healing period, followed by complete resorption without causing harm to the surrounding tissues. This challenge drives significant research in the design and development of bioresorbable materials, such as polylactic acid (PLA) and polycaprolactone (PCL), which offer favorable characteristics like flexibility and gradual dissolution.
The North American market also sees significant demand for bioresorbable stents in the growing trend toward minimally invasive surgeries. Healthcare providers prefer devices that reduce complications, lower infection rates, and accelerate recovery times, driving the demand for BRS technology. Additionally, government regulations and reimbursement policies play a crucial role in shaping the market, influencing manufacturers to align their products with safety standards and affordability for patients.
As the North American bioresorbable stent market continues to expand, it remains a dynamic sector with immense potential to improve the outcomes of cardiovascular treatments. The collaboration between medical device manufacturers, researchers, and healthcare professionals will be key in driving innovations that fulfill the needs of the healthcare industry and benefit patients.
North America Bioresorbable Stent (BRS) Device Market
Get an In-Depth Research Analysis of the North America Bioresorbable Stent (BRS) Device Market Size And Forecast [2025-2032]
Lepu Medical
Biotronik
Abbott
REVA
MeKo
Boston Scientific Corporation
Arterius Limited
Kyoto Medical Planning Co. Ltd
Terumo Corporation
Elixir Medical Corporation
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the North America Bioresorbable Stent (BRS) Device Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the North America Bioresorbable Stent (BRS) Device Market
Coronary Artery Disease
Peripheral Artery Disease
Based on Types the Market is categorized into Below types that held the largest Bioresorbable Stent (BRS) Device market share In 2023.
Polymer-based Bioabsorbable Stents
Metal-based Bioabsorbable Stents
North America (United States, North America and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Bioresorbable Stent (BRS) Device Market Research Analysis
1. Introduction of the North America Bioresorbable Stent (BRS) Device Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. North America Bioresorbable Stent (BRS) Device Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. North America Bioresorbable Stent (BRS) Device Market, By Type
6. North America Bioresorbable Stent (BRS) Device Market, By Application
7. North America Bioresorbable Stent (BRS) Device Market, By Geography
North America
Europe
Asia Pacific
Rest of the World
8. North America Bioresorbable Stent (BRS) Device Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading North America Research and Consulting firm servicing over 5000+ North America clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/